Condition: Head and Neck Cancer · Oral Cavity Cancer · Oropharyngeal Cancer · Sponsor: University of Erlangen-Nürnberg Medical School
The aim of this prospective non-interventional multi-center trial is to study the prognostic value of intratumoral and systemic immune biomarkers in newly diagnosed non-metastatic head and neck cancer. Furthermore, the local immunological processes in the tumor will be correlated with the systemic immune status determined in the peripheral blood to identify prognostic immune signatures. In addition, tumor organoids will be generated ex vivo for functional biological analyses. The main objective is to create a prognostic score determined by clusters based on tumor immunologic criteria.
This description comes directly from the study's public registry record.
Antoniu-Oreste Gostian, PD Dr. med. · +49 9131 85-33156 · antoniu-oreste.gostian@uk-erlangen.de
Always discuss trial participation with your own doctor first.
| ENT - Head and Neck Surgery Department | Erlangen, Bavaria, Germany | Recruiting |
| Maxillo-Facial-Surgery Department | Erlangen, Bavaria, Germany | Recruiting |
| Radiation Oncology Department | Erlangen, Bavaria, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05375266